Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Oncorus Inc stock

Learn how to easily invest in Oncorus Inc stock.

Oncorus Inc is a biotechnology business based in the US. Oncorus Inc shares (ONCR) are listed on the NASDAQ and all prices are listed in US Dollars. Oncorus Inc employs 82 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Oncorus Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ONCR – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Oncorus Inc stock price (NASDAQ: ONCR)

Use our graph to track the performance of ONCR stocks over time.

Oncorus Inc shares at a glance

Information last updated 2022-06-24.
Latest market close$1.35
52-week range$0.98 - $16.01
50-day moving average $1.31
200-day moving average $4.56
Wall St. target price$9.60
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.71

Buy Oncorus Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
Financial advice powered by relationships, not commissions.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Oncorus Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Oncorus Inc price performance over time

Historical closes compared with the close of $1.35 from 2022-06-28

1 week (2022-06-22) -10.00%
1 month (2022-05-27) 13.92%
3 months (2022-03-30) -25.82%
6 months (2021-12-30) -75.41%
1 year (2021-06-30) -90.22%
2 years (2020-06-26) N/A
3 years (2019-06-26) N/A
5 years (2017-06-26) N/A

Oncorus Inc financials

Gross profit TTM $0
Return on assets TTM -21.77%
Return on equity TTM -48.11%
Profit margin 0%
Book value $4.41
Market capitalisation $41.4 million

TTM: trailing 12 months

Oncorus Inc share dividends

We're not expecting Oncorus Inc to pay a dividend over the next 12 months.

Oncorus Inc overview

Oncorus, Inc. , a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Frequently asked questions

What percentage of Oncorus Inc is owned by insiders or institutions?
Currently 8.968% of Oncorus Inc shares are held by insiders and 76.957% by institutions.
How many people work for Oncorus Inc?
Latest data suggests 82 work at Oncorus Inc.
When does the fiscal year end for Oncorus Inc?
Oncorus Inc's fiscal year ends in December.
Where is Oncorus Inc based?
Oncorus Inc's address is: 50 Hampshire Street, Cambridge, MA, United States, 02139
What is Oncorus Inc's ISIN number?
Oncorus Inc's international securities identification number is: US68236R1032

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site